Prenetics Global Limited (PRE) Insider Trading Activity

NASDAQ$16.1-0.09 (-0.56%)
Market Cap
$274.22M
Sector
Consumer Defensive
Industry
Household & Personal Products
Rank in Sector
24 of 164
Rank in Industry
3 of 25

PRE Insider Trading Activity

PRE Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$999,698
4
100
Sells
$0
0
0

Related Transactions

Yeung Danny Sheng WuChief Executive Officer
2
$501,998
0
$0
$501,998
Rosin Brian JCFO of IM8 (US) LLC
2
$497,700
0
$0
$497,700

About Prenetics Global Limited

Prenetics Global Limited is a consumer health sciences company that has pivoted to focus on a consumer health and longevity platform. The company's main brand is IM8, which offers science-backed nutritional supplements. It also operates CircleDNA, a consumer genetic testing brand that provides personalized health reports based on sequencing technology.

Insider Activity of Prenetics Global Limited

Over the last 12 months, insiders at Prenetics Global Limited have bought $999,698 and sold $0 worth of Prenetics Global Limited stock.

On average, over the past 5 years, insiders at Prenetics Global Limited have bought $999,698 and sold $0 worth of stock each year.

Highest buying activity among insiders over the last 12 months: Yeung Danny Sheng Wu (Chief Executive Officer) — $501,998. Rosin Brian J (CFO of IM8 (US) LLC) — $497,700.

The last purchase of 5,100 shares for transaction amount of $116,280 was made by Rosin Brian J (CFO of IM8 (US) LLC) on 2026‑08‑25.

List of Insider Buy and Sell Transactions, Prenetics Global Limited

2026-08-25PurchaseRosin Brian JCFO of IM8 (US) LLC
5,100
0.0294%
$22.80
$116,280
-3.35%
2026-08-24PurchaseYeung Danny Sheng WuChief Executive Officer
17,181
0.0968%
$21.23
$364,673
+3.53%
2026-08-24PurchaseRosin Brian JCFO of IM8 (US) LLC
18,000
0.1012%
$21.19
$381,420
+3.53%
2026-08-20PurchaseYeung Danny Sheng WuChief Executive Officer
7,500
0.0443%
$18.31
$137,325
+23.79%
2015-12-21SaleDesmet LaurieEVP & COO, PartnerRe Ltd
710
0.1805%
$139.11
$98,770
2015-09-17SaleSAUTTER REMYdirector
5,282
1.3362%
$138.46
$731,338
2015-09-16SaleSAUTTER REMYdirector
15,613
3.9498%
$138.46
$2.16M
2015-02-05SaleWalker Theodore CPresident & CEO, PartnerRe NA
2,874
0.6357%
$121.06
$347,933
2014-11-28SaleClarke EmmanuelCEO, PartnerRe Global
500
0.107%
$117.15
$58,575
2014-10-31SaleClarke EmmanuelCEO, PartnerRe Global
2,000
0.4237%
$115.96
$231,920
2014-10-23SaleClarke EmmanuelCEO, PartnerRe Global
500
0.1051%
$115.00
$57,500
2014-09-02SaleClarke EmmanuelCEO, PartnerRe Global
500
0.1032%
$113.00
$56,500
2014-08-25SaleClarke EmmanuelCEO, PartnerRe Global
500
0.1014%
$111.00
$55,500
2014-08-25SaleSAUTTER REMYdirector
5,549
1.1177%
$110.25
$611,777
2014-08-21SaleSAUTTER REMYdirector
1,719
0.3463%
$110.26
$189,545
2014-08-20SaleMONTUPET JEAN PAUL Ldirector
2,441
0.4808%
$107.81
$263,164
2014-06-27SaleWalker Theodore CPresident & CEO, PartnerRe NA
6,061
1.2%
$108.37
$656,825
2014-06-06SaleClarke EmmanuelCEO, PartnerRe Global
150
0.0299%
$109.12
$16,368
2014-06-05SaleClarke EmmanuelCEO, PartnerRe Global
500
0.0995%
$108.90
$54,450
2014-06-05SaleOuttrim DavidChief Accounting Officer
1,894
0.3745%
$108.21
$204,955
Total: 119
*Gray background shows transactions not older than one year

PRE Institutional Investors: Active Positions

Increased Positions25+138.89%614,569+47.42%
Decreased Positions7-38.89%170,533-13.16%
New Positions20New560,277New
Sold Out Positions3Sold Out74,684Sold Out
Total Postitions36+100%2M+34.26%

PRE Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Prudential Plc$6,753.003.29%427,96300%2025-09-30
Aspex Management (Hk) Ltd$5,462.002.66%346,15000%2025-09-30
Nomura Holdings Inc$5,002.002.44%316,999-4,826-1.5%2025-09-30
Aberdeen Group Plc$1,162.000.57%73,621+73,621New2025-09-30
Ubs Group Ag$735.000.36%46,561+39,733+581.91%2025-09-30
Renaissance Technologies Llc$414.000.2%26,222+26,222New2025-09-30
Blackrock, Inc.$368.000.18%23,289-1,533-6.18%2025-09-30
Stevens Capital Partners$274.000.13%17,38200%2025-09-30
Morgan Stanley$155.000.08%9,824+900+10.09%2025-09-30
Jpmorgan Chase & Co$77.000.04%4,900+4,900New2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.